Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease. - Wikidata - awgldk - TriplyDB

Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.

Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.

http://www.wikidata.org/entity/Q42662957

about

Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease Exacerbations of COPD A rational approach to single, dual and triple therapy in COPD Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review Asthma-COPD Overlap Syndrome: What We Know and What We Don't.Mechanisms of corticosteroid insensitivity in COPD alveolar macrophages exposed to NTHi Blood and sputum eosinophils in COPD; relationship with bacterial load.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in Chronic Obstructive Pulmonary Disease? Results from Post Hoc Subgroup Analyses.Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on As Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on As Optimum treatment for chronic obstructive pulmonary disease exacerbation prevention.Drugs for chronic obstructive pulmonary disease Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD When is dual bronchodilation indicated in COPD?Fluticasone propionate/formoterol for COPD management: a randomized controlled trial.Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.Reply to Correspondence Letter Regarding "Blood Eosinophils and Response to Maintenance COPD Treatment: Data from the FLAME Trial".Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease.Stability of Blood Eosinophil Count in Patients with COPD in the UK Clinical Practice Research Datalink.Prediction and prevention of exacerbations and mortality in patients with COPD.Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study.How Do Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence.Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD.Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease Systemic White Blood Cell Count as a Biomarker for Chronic Obstructive Pulmonary Disease: Utility and Limitations Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma.Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide.Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.Recommendations for the pharmacological treatment of COPD: questions and answers.

P2860

Q26745663-385E9608-2E05-4A8D-8801-A1412BC68FBE Q26764891-D1BE40BB-096A-4BF1-A3C6-97D18459B41C Q26776477-C7F2FBEA-9595-4512-B41C-BCC8B4C32254 Q28070274-B2FB0C2D-9CA4-41B4-BDA2-9DC479EF9E9D Q30238799-CE652C88-72AE-41B0-AC83-FA8DAD003719 Q33576458-F73B9924-3A02-469B-8EE5-62F4E19C4D2F Q33651114-6C823EE3-440B-4C3D-A846-35ECDB3E06C9 Q34550471-682DE8DD-4EAF-4661-9FF1-F10CCAC5B610 Q36084073-BE67CB21-501E-456F-B804-DD50727DDC3E Q36302882-E15EF0CB-BD71-4138-BFB0-6480FB7E9086 Q36332206-D4EB200A-1E83-4719-9E3A-0A4184CBDE73 Q37074953-CB51E142-9081-4AB3-9AB5-925DFAD57C2A Q37283465-8144102F-55C2-4407-AC9B-81EB3C48F826 Q37374602-E065F455-780B-4E89-9594-060BBD601E95 Q37481285-8E9F491E-44DB-43F0-BEF7-D5341EF35E77 Q37583834-95F5C53B-DD1F-4CC8-9210-4009A6CD66C2 Q37647174-A426CE30-790C-4A6A-B23E-6BF9776877D9 Q38621360-1D15CE82-B0CA-4C28-A8DC-95080BAA5D3F Q38641441-30E9E684-05C7-45E2-9EE8-82A5961567DA Q38663441-ECCA48D4-0C05-4355-B8E5-B2EB04C1E1EA Q38685218-2999B05D-C1B1-4D91-BB90-21D67BCDCFFF Q38708919-AB1E2E2F-35AC-44AB-9F52-38BF72101560 Q38710985-42CD0DE8-5533-434F-B0F6-81D5F93015E0 Q38751378-F8C06524-50AC-4F78-9559-7CDB24AA2C3C Q38823010-487E85BA-5936-4E45-BA14-3867CDD24D46 Q38901257-BEC2AE4F-9377-45C3-A45C-2067BB803B62 Q38934768-C1FEF37F-729A-4486-8C4C-9E644CBCF0AF Q39030602-21BB5D12-F00C-4767-86DA-B7693632E44A Q39094807-92C7283E-9BA4-4B30-AA92-930DFFA7BC6F Q39173650-9B3FFD1C-8C3B-4D75-88A7-008B74857F9D Q39367877-6D850843-E6EC-45D2-99E9-354096A0D742 Q40598255-A8285414-A45F-499E-A3C6-776B60378F9D Q41658426-CF445E8E-0948-4686-B5D7-0DD50DD98E72 Q42337197-DBC4554C-2F06-4123-9CB5-F65A699B97FF Q42358548-A82478B1-387C-4371-A838-505AB0EEF1E3 Q42701518-928C71A6-1822-455A-921C-0546004FAFB8 Q42920605-FDED404E-D616-4684-9D52-70932C939E8F Q46434748-7522E0C1-7DD3-48A6-9514-E5DE9AF55145 Q47138049-A5AADF85-0F0D-452D-AF63-23C8226582FB Q47272746-6970F9BC-0942-4FF5-BED2-0205AE39033C

P2860

Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.

http://www.wikidata.org/entity/Q42662957

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease.

@en

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease.

@nl

type

label

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease.

@en

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease.

@nl

prefLabel

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease.

@en

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease.

@nl

P1433

Q42662957-90BB27BA-8817-4569-BF8C-061D60B18B5C

P1476

Q42662957-00D73AA2-987C-4E98-8CAC-CCA52FA72AAA

P2093

Q42662957-35F00BA5-B037-48B2-B30C-C4DBB6FAB4F2

Q42662957-370320F2-F9F0-43F6-A355-98CD04919F01

Q42662957-50565717-2CB6-49B1-96AE-05F8F3530A57

Q42662957-6D0A0898-4ECE-466E-A858-0AEFC7E6E4F9

Q42662957-D7697A42-A6D9-42D4-A5C0-A1F024B416AC

Q42662957-DF0EA7F0-86BE-4318-8051-A99CF8D725BC

Q42662957-FAF0595D-A875-45E2-81A7-E9F329806BBA

P2860

Q42662957-13BC4BE1-9795-40FD-8E64-9652C51D048F

Q42662957-1FD917EE-ECDF-4BEF-BC7F-D9122D214213

Q42662957-28A0BC99-4C4A-4AA9-AA71-166A8AEAC066

Q42662957-4E6EBBA5-2DA8-4F08-8D1E-FA792E9882F4

Q42662957-67C24A60-02E0-4817-8046-327CBEC51689

Q42662957-CAFC347F-4386-45A7-90A1-0E58833916F7

Q42662957-CE12CE4E-6B03-4B15-B671-460FC803E71E

P304

Q42662957-74B939A9-47DC-4B24-A93C-72BD28DF8197

P31

Q42662957-C9754F60-B6BB-456E-88CF-3F19969942DA

P356

Q42662957-6A0F6CC3-1D3D-4DDE-96AA-9A954A06CAB8

P407

Q42662957-CAC78080-8504-4C2A-AEEE-B345A499E5AA

P433

Q42662957-85CA70F6-F770-4292-8CDA-994C101C1CBD

P478

Q42662957-F92C242B-4B59-4AF4-847C-E2C1A4EB0C12

P50

Q42662957-79D4F718-F7C1-47D2-98F4-A17ADB0BC8A4

P577

Q42662957-2C86E16E-341C-4312-B174-44FBA4C9FF35

P698

Q42662957-B95AA23A-24AE-4C42-BB66-9D5824D2D019

P921

Q42662957-302C15A9-0F49-4CA4-8649-22E2D32CCFCD

Q42662957-B6B75409-35FE-430C-926F-3FA339617C6F

P932

Q42662957-DDF43552-5033-430C-9606-3BE61AFE3669

P356

RCCM.201502-0235LE

P1433

American Journal of Respiratory and Critical Care Medicine

P1476

Blood Eosinophils: A Biomarker ...... Obstructive Pulmonary Disease

@en

P2093

Alessandro Guasconi

http://www.w3.org/2001/XMLSchema#string

Alvar Agusti

http://www.w3.org/2001/XMLSchema#string

Dave Singh

http://www.w3.org/2001/XMLSchema#string

Jadwiga A Wedzicha

http://www.w3.org/2001/XMLSchema#string

Jørgen Vestbo

http://www.w3.org/2001/XMLSchema#string

Paul Jones

http://www.w3.org/2001/XMLSchema#string

Pierluigi Paggiaro

http://www.w3.org/2001/XMLSchema#string

P2860

Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial

The path to personalised medicine in COPD.

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.

Eosinophilic inflammation in COPD: prevalence and clinical characteristics.

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.

Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations.

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

P304

523-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1164/RCCM.201502-0235LE

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

192

http://www.w3.org/2001/XMLSchema#string

P50

Salman H Siddiqui

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26051430

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

4595668

http://www.w3.org/2001/XMLSchema#string